Active start on export of Celltrion’s antibody biosimilar Remsima to U.S.

Published: 2016-10-31 13:17:13

Updated: 2016-10-31 13:59:11

A Celltrion’s affiliate, Celltrion Healthcare announced it will begin to export Remsima(U.S. product name: Inflectra) from its release data on November.

Through its joint news release on the 18^th of October, Celltrion Healthcare and Pfizer announced the Remsima’s U.S. release date on November, and finished agreements related to its supply to the U.S.

According to Celltrion, Celltrion Healthca...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.